It is an eminent goal of GEISTER to cooperate with medical doctors in creating an ever wider userplatform for more gentle cardiovascular surgery techniques, and to make such techniques available worldwide. Heart valves have been traditionally approached through a median sternotomy. 

However, significant advances in optics and surgical instrumentation, such as the original GEISTER ValveGate™ Instruments, have allowed for mitral and aortic valve replacement or repair to be performed using progressively smaller incisions. Minimally invasive mitral valve surgery has now become a standard of care at many specialized centers worldwide. Patients can a.o. usually benefit from shorter hospital stays, less pain and scarring, less risk of ingection, less blood loss and faster recovery. 

With the Maazouzi APS™ system an initial biomedical solution has been developed for using the body’s own tissue material from the pericardium to reconstruct or completely replace the defective heart valve. The economical and reproducible procedure permits easier access to the therapy for the mostly still very young patients there – an important step towards preventive strategies, tailored together with GEISTER to the specific socio-economic circumstances with distinguished product and process solutions for cardiovascular surgery.